1. The Patient’s Voice in Pharmacovigilance: Pragmatic Approaches to Building a Patient-Centric Drug Safety Organization

   • Meredith Y. Smith
   • Isma Benattia

   Current Opinion Open access 20 April 2016 Pages: 779 - 785

   

2. Benefit–Risk Assessment of Fish Oil in Preventing Cardiovascular Disease

   • Bill Lands

   Review Article Open access 13 July 2016 Pages: 787 - 799

   

3. Drug-Induced Liver Injury: Highlights from a Review of the 2015 Literature

   • Philip Sarges
   • Joshua M Steinberg
   • James H Lewis

   Review Article 03 May 2016 Pages: 801 - 821

4. Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster

   • Kunihiro Yamaoka

   Review Article 18 May 2016 Pages: 823 - 840

5. Drug Interactions of Direct-Acting Oral Anticoagulants

   • John Leonard Fitzgerald
   • Laurence Guy Howes

   Review Article 19 July 2016 Pages: 841 - 845

6. Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors

   • Mulugeta Tarekegn Angamo
   • Leanne Chalmers
   • Luke R. E. Bereznicki

   Review Article 23 July 2016 Pages: 847 - 857

   

7. Active Surveillance versus Spontaneous Reporting for First-Line Antiretroviral Medicines in Namibia: A Cost–Utility Analysis

   • Marita Mann
   • Assegid Mengistu
   • Andy Stergachis

   Original Research Article 17 June 2016 Pages: 859 - 872

   

8. Drug Safety Monitoring in Children: Performance of Signal Detection Algorithms and Impact of Age Stratification

   • Osemeke U. Osokogu
   • Caitlin Dodd
   • Miriam C. J. M. Sturkenboom

   Original Research Article Open access 02 June 2016 Pages: 873 - 881